A simple relationship between viral load and survival time in HIV-1 infection.

Despite important recent insights into the short-term dynamics of HIV-1 infection, our understanding of the long-term pathogenesis of AIDS remains unclear. Using an approach that places rapid progressors, typical progressors, and nonprogressors on a single clinical spectrum of disease progression, we quantitate the previously reported relationship between viral load and survival time. We introduce the concept of viral constant, present evidence that this quantity is conserved across patients, and explore the immunopathological implications of this finding. We conclude with a quantitative approach for assessing the benefits of a given regime of antiviral therapy.

[1]  Anthony S. Fauci,et al.  Toward an Understanding of the Correlates of Protective Immunity to HIV Infection , 1996, Science.

[2]  R. Grant,et al.  High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. , 1998, The Journal of clinical investigation.

[3]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .

[4]  J. Goedert,et al.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. , 1987, JAMA.

[5]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[6]  M A Nowak,et al.  Antigenic diversity thresholds and the development of AIDS. , 1991, Science.

[7]  E. Vittinghoff,et al.  The characterization of non‐progressors: long‐term HIV‐1 infection with stable CD4+ T‐cell levels , 1993, AIDS.

[8]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[9]  J J Goedert,et al.  Longitudinal HIV-1 RNA levels in a cohort of homosexual men. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[10]  S. J. Clark,et al.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.

[11]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[12]  R P Johnson,et al.  Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Alan S. Perelson,et al.  Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.

[14]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[15]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[16]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[17]  Louis J. Picker,et al.  Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.

[18]  J. Margolick,et al.  Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection : A comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and β2-microglobulin , 1997 .

[19]  A S Perelson,et al.  Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.

[20]  I Spijkerman,et al.  AIDS prognosis based on HIV‐1 RNA, CD4+ T‐cell count and function: markers with reciprocal predictive value over time after seroconversion , 1997, AIDS.

[21]  R. Siliciano,et al.  Viral Dynamics in HIV-1 Infection , 1998, Cell.

[22]  J. Mittler,et al.  Modeling T-cell proliferation: an investigation of the consequences of the Hayflick limit. , 1997, Journal of theoretical biology.

[23]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[24]  J. Goedert,et al.  Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. , 1996, JAMA.

[25]  J. Goedert,et al.  Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia , 1998, AIDS.

[26]  A. Fauci,et al.  Immunopathogenesis of HIV infection. , 1996, Annual review of microbiology.

[27]  Martin A. Nowak,et al.  The frequency of resistant mutant virus before antiviral therapy , 1998, AIDS.

[28]  N. Jewell,et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. , 1989, Journal of acquired immune deficiency syndromes.

[29]  A. McMichael,et al.  T Cell Responses and Viral Escape , 1998, Cell.

[30]  M A Nowak,et al.  Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Valerie Isham,et al.  Models for Infectious Human Diseases: Their Structure and Relation to Data , 1996 .

[32]  D. Ho,et al.  Viral Counts Count in HIV Infection , 1996, Science.

[33]  C. Boucher,et al.  Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. , 1998, The Journal of infectious diseases.

[34]  J J Goedert,et al.  Natural history of HIV-1 cell-free viremia. , 1995, JAMA.

[35]  B. Clotet,et al.  Lack of evidence of a stable viral load set‐point in early stage asymptomatic patients with chronic HIV‐1 infection , 1998, AIDS.

[36]  F. Mazzotta,et al.  Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[37]  K. Harada,et al.  Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.